This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • Adamis Pharmaceuticals resubmits NDA for Zimhi for...
News

Adamis Pharmaceuticals resubmits NDA for Zimhi for the treatment of opioid overdose..

Read time: 1 mins
Last updated:20th May 2020
Published:19th May 2020
Condition: Opioid Dependence/Overdose
Type: drug
Register now for full access to medthority.com